Strategic establishment of an International Pharmacology Specialty Laboratory in a resource-limited setting
- PMID: 29535916
- PMCID: PMC5843799
- DOI: 10.4102/ajlm.v7i1.659
Strategic establishment of an International Pharmacology Specialty Laboratory in a resource-limited setting
Abstract
Background: A growing number of drug development studies that include pharmacokinetic evaluations are conducted in regions lacking a specialised pharmacology laboratory. This necessitated the development of an International Pharmacology Specialty Laboratory (IPSL) in Zimbabwe.
Objectives: The aim of this article is to describe the development of an IPSL in Zimbabwe.
Methods: The IPSL was developed collaboratively by the University of Zimbabwe and the University at Buffalo Center for Integrated Global Biomedical Sciences. Key stages included infrastructure development, establishment of quality management systems and collaborative mentorship in clinical pharmacology study design and chromatographic assay development and validation.
Results: Two high performance liquid chromatography instruments were donated by an instrument manufacturer and a contract research organisation. Laboratory space was acquired through association with the Zimbabwe national drug regulatory authority. Operational policies, standard operating procedures and a document control system were established. Scientists and technicians were trained in aspects relevant to IPSL operations. A high-performance liquid chromatography method for nevirapine was developed with the guidance of the Clinical Pharmacology Quality Assurance programme and approved by the assay method review programme. The University of Zimbabwe IPSL is engaged with the United States National Institute of Allergy and Infectious Diseases Division of AIDS research networks and is poised to begin drug assays and pharmacokinetic analyses.
Conclusions: An IPSL has been successfully established in a resource-limited setting through the efforts of an external partnership providing technical guidance and motivated internal faculty and staff. Strategic partnerships were beneficial in navigating challenges leading to laboratory development and training new investigators. The IPSL is now engaged in clinical pharmacology research.
Conflict of interest statement
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
References
-
- UZCHS-CTU University of Zimbabwe College of Health Sciences Clinical Trials Unit; 2017 [Our research]. Available from: http://www.uz-ucsf.co.zw/research/
-
- Mudzviti T, Maponga CC, Khoza S, et al. . The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in Zimbabwe. AIDS Res Treat. 2012;2012:4 https://doi.org/10.1155/2012/434171 - DOI - PMC - PubMed
-
- Monera-Penduka TG, Maponga CC, Morse GD, et al. . Capacity for ethical and regulatory review of herbal trials in developing countries: A case study of Moringa oleifera research in HIV-infected patients. J Pharm Policy Pract. 2017;10(1):9 https://doi.org/10.1186/s40545-017-0099-5 - DOI - PMC - PubMed
-
- National Research Council Panel on Collecting Storing, Accessing, Protecting Biological Specimens, Biodata in Social Surveys The national academies collection: Reports funded by National Institutes of Health. In: Hauser RM, Weinstein M, Pool R, et al. , editors. Conducting biosocial surveys: Collecting, storing, accessing, and protecting biospecimens and biodata. Washington, DC: National Academies Press (US) National Academy of Sciences; 2010:1–2 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources